services revenue was $10 million for the quarter, down 5%.
Annual software and services revenue was $39 million, up 17%. Software and
services revenue growth in the year came from several areas: 1) the
acquisition of IDM, Inc. in January 2007; 2) the integration of the
Surround software suite into the operations of Hema Quebec, completing the
integration of Surround into all Canadian blood testing; and 3) the ongoing
management of and enhancements to the U.S. Department of Defense's Defense
Blood Standard System.
Surgical disposables revenue was $21 million, up 23% for the quarter.
Annual Surgical disposables revenue was $72 million, up 8%. Growth for the
quarter and year was driven by the TEG product line which Haemonetics
acquired in November 2007.
OrthoPAT(R) disposables revenue was $9 million for the quarter, up 10%.
Annual OrthoPAT disposables revenue was $34 million, up 12%. The Company
placed more than 175 OrthoPAT devices in the field in fiscal 2008.
Equipment placements are expected to continue to drive disposables growth
into fiscal 2009.
Equipment revenue was $11 million for the quarter, up 50%, and $33
million for the year, up 48%. Equipment sales growth was driven by sales of
plasma devices in the growing European and Asian markets, platelet
equipment in Europe, and red cell equipment in the U.S.
FISCAL 2009 SHARE REPURCHASE PLAN
Haemonetics said today that its Board of Directors has authorized a $60
million share repurchase program.
FISCAL 2009 GUIDANCE
Haemonetics announced its fiscal 2009 guidance. In fiscal 2009, the
Company anticipates revenue growth of 8-11%, with growth again being driven
by multiple product lines. Growth is planned from plasma, red cells,
software, OrthoPAT, internal new products, and the acquired TEG product
line. Adjusted operating income is expected to grow 14-17%, and adjusted
earnings per share are expected to be in a range of $2.31 to $2.41, up
10-14%.
The Company fu
'/>"/>
SOURCE Haemonetics Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine news :1.
Haemonetics Webcast Presentation2.
Keiko Hattori Joins Haemonetics as President of Haemonetics Japan3.
Haemonetics Appoints Executive Leadership of European Operations4.
Haemonetics Sets Date for Q3FY08 Earnings Release and Conference Call - January 31, 20085.
Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales6.
Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers7.
Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 20088.
New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites9.
Haemacure Reports Third Quarter 2007 Results10.
First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion11.
Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best